| 注册
首页|期刊导航|中国药业|复方益肝灵对抗结核药物致肝损伤患者血清前白蛋白等指标的影响

复方益肝灵对抗结核药物致肝损伤患者血清前白蛋白等指标的影响

赵雪 许春明

中国药业Issue(22):59-60,2.
中国药业Issue(22):59-60,2.

复方益肝灵对抗结核药物致肝损伤患者血清前白蛋白等指标的影响

Influence of Compound Yiganling Capsules on Serum Prealbumin of Patients with Liver Damage Induced by Anti-Tuberculosis Drugs

赵雪 1许春明2

作者信息

  • 1. 北京市房山区疾病预防控制中心,北京 102488
  • 2. 北京市房山区结核病防治所,北京 102488
  • 折叠

摘要

Abstract

Objective To observe the influence of compound Yiganling Capsules on serum prealbumin(PAB)of patients with liver dam-age induced by anti-tuberculosis drugs. Methods 100 patients were randomly divided into the treatment group and the control group, 50 cases in each group. The control group received regular treatment,the treatment group received regular treatment and compound Yiganling Capsules. Results After treatment,the levels of ALT and AST in the two groups significantly increased than before treatment ( P < 0. 05),but the treatment group was significantly lower than the control group( P < 0. 05);the serum PAB and total protein in the two groups significantly decreased than before treatment,but the PAB of the treatment group was significantly lower than that of the control group( P < 0. 05);the total protein of the treatment group had no significant difference than before treatment,but the control group had( P < 0. 05);the percentage of liver damage was 6. 00% of the treatment group,and 10. 00% of the control grou,which had no significant difference( P > 0. 05). Conclusion Compound Yiganling Capsules combined with anti-tuberculosis drugs can reduce the liver damage induced by anti-tuberculosis drugs with less adverse reactions.

关键词

复方益肝灵胶囊/抗结核药物/肝损伤/血清前白蛋白/药品不良反应

Key words

Compound Yiganling Capsules/anti-tuberculosis drugs/liver damage/serum prealbumin/adverse drug reactions

分类

医药卫生

引用本文复制引用

赵雪,许春明..复方益肝灵对抗结核药物致肝损伤患者血清前白蛋白等指标的影响[J].中国药业,2015,(22):59-60,2.

中国药业

1006-4931

访问量0
|
下载量0
段落导航相关论文